ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,519,309 | +8.0% | 16,225 | +2.9% | 0.00% | 0.0% |
Q2 2023 | $1,407,295 | -5.2% | 15,768 | +13.9% | 0.00% | 0.0% |
Q1 2023 | $1,484,676 | -1.3% | 13,847 | +12.4% | 0.00% | 0.0% |
Q4 2022 | $1,504,763 | +16.3% | 12,321 | -1.8% | 0.00% | 0.0% |
Q3 2022 | $1,294,000 | +24.9% | 12,541 | +12.6% | 0.00% | 0.0% |
Q2 2022 | $1,036,000 | -0.8% | 11,134 | +25.2% | 0.00% | 0.0% |
Q1 2022 | $1,044,000 | -19.4% | 8,894 | -7.7% | 0.00% | 0.0% |
Q4 2021 | $1,296,000 | -12.5% | 9,632 | +3.6% | 0.00% | 0.0% |
Q3 2021 | $1,481,000 | +41.5% | 9,293 | +16.9% | 0.00% | 0.0% |
Q2 2021 | $1,047,000 | +9.5% | 7,950 | +7.2% | 0.00% | 0.0% |
Q1 2021 | $956,000 | +8.1% | 7,416 | +40.0% | 0.00% | 0.0% |
Q4 2020 | $884,000 | -3.3% | 5,299 | -10.5% | 0.00% | 0.0% |
Q3 2020 | $914,000 | +2.0% | 5,922 | -2.4% | 0.00% | 0.0% |
Q2 2020 | $896,000 | +28.2% | 6,066 | -2.2% | 0.00% | 0.0% |
Q1 2020 | $699,000 | -13.8% | 6,204 | +6.6% | 0.00% | 0.0% |
Q4 2019 | $811,000 | +45.1% | 5,822 | +0.2% | 0.00% | 0.0% |
Q3 2019 | $559,000 | -13.2% | 5,811 | +3.7% | 0.00% | 0.0% |
Q2 2019 | $644,000 | +51.2% | 5,603 | +54.8% | 0.00% | – |
Q1 2019 | $426,000 | +5.4% | 3,620 | -43.8% | 0.00% | – |
Q4 2018 | $404,000 | -15.8% | 6,440 | -4.7% | 0.00% | – |
Q3 2018 | $480,000 | +37.1% | 6,760 | +28.5% | 0.00% | – |
Q2 2018 | $350,000 | – | 5,260 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |